Showing results (1-10 of 571) with videos related to

Sort By:
Pageof 58
Current Drug Targets|October 25, 2014
CYLD-mediated signaling and diseasesBryan J Mathis, Yimu Lai, Chen Qu, et al.
Journal of Molecular and Cellular Cardiology|May 4, 2015
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2Hui Wang, Yimu Lai, Bryan J Mathis, et al.
Advances in Experimental Medicine and Biology|October 25, 2016
CDDO and Its Role in Chronic DiseasesBryan J Mathis, Taixing Cui
Biochemical and Biophysical Research Communications|February 4, 2014
Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2Bin Li, Akram Abdalrahman, Yimu Lai, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2015
Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytesTaixing Cui, Yimu Lai, Jospeh S Janicki, et al.
Expert Opinion on Therapeutic Targets|June 18, 2009
Targeting the Nrf2 pathway against cardiovascular diseaseJinqing Li, Tomonaga Ichikawa, Joseph S Janicki, et al.
Oxidative Medicine and Cellular Longevity|June 5, 2014
Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunctionSiying Li, Wenjuan Wang, Ting Niu, et al.
Journal of Molecular and Cellular Cardiology|April 22, 2014
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteinsWenjuan Wang, Siying Li, Hui Wang, et al.
Pageof 58